A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples